Account:
Ottawa, Canada, May 25, 2010 – Sussex Research Laboratories Inc. has appointed Wako Pure Chemical Industries (Osaka, Japan) as a non-exclusive distributor of Sussex’s complete line of carbohydrate-based reagents (glycoreagents) in Japan. Sussex Research develops and manufactures sophisticated carbohydrate-based molecules for advanced academic research as well as for research & development in the pharmaceutical and biotechnology industries.
Under the new distribution agreement, Sussex glycoreagents are to be marketed under the Sussex Research label and sold, in research quantities, via Wako’s catalogue, sub-distributors and dealer network throughout Japan.
According to Brady Clark, Ph.D., President of Sussex Research, “We are very pleased to be working with Wako, which is renowned for its high purity chemical reagents. We perceive Wako as the leader in Japan for the provision of premium quality research reagents. Scientists in Japan are highly recognized for contributions in glycoscience. This collaboration will extend our ability to make these important glycoreagents including glycoamino acids, glycopeptides, oligosaccharides, PEGylated Glycosides and other unique carbohydrate-based molecules and glycoconjugates available to researchers in Japan.”
About Sussex Research: Sussex Research is a well known specialist in carbohydrate synthesis with an established international reputation. As a carbohydrate-enabling company, Sussex Research excels in the design, synthesis and characterization of carbohydrate-based molecules. The company’s unique product portfolio and custom synthesis service enables researchers across a variety of scientific disciplines to readily explore and exploit carbohydrates and carbohydrate modified molecules such as glycoamino acids, glycopeptides, oligosaccharides, special carbohydrate linker/spacer systems and other glycoconjugates in numerous and diverse applications.
SHARE THIS ARTICLE ON:
Get product updates and announcements from Sussex Research in your inbox at no charge.
Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2022: Oligonucleotide & Peptide Therapeutics
May 4, 2022
Sussex Research Laboratories Inc. to Exhibit at The American Peptide Symposium 2022 - "Peptide Science at the Summit"
April 26, 2022
Sussex Research Laboratories Inc. / Queen’s University collaboration receives support to develop novel small molecule therapies for COVID-19
May 21, 2020
Sussex Research Laboratories Inc. / Queen’s University collaboration receives Collaborative Research and Development Grant (CRDPJ) to develop synthetic strategies toward Deuterium-labeled pharmaceutical compounds with improved efficacy.
August 22, 2018
Sussex Research Laboratories Inc. acquires Chemaphor Chemical Services from Avivagen
October 13, 2017